Since the last major revision of the GINA report in 2006 [12], there has been a transition in understanding of asthma and chronic obstructive pulmonary disease (COPD) as heterogeneous and sometimes overlapping conditions, awareness of the contribution of common problems such as adherence, inhaler technique and health literacy to poorly controlled asthma, an expanding research evidence base that incorporates highly controlled efficacy studies, pragmatic studies and observational data in broad populations [13], increasing interest in individualised healthcare, and growing attention to effective strategies for changing health-related behaviour. This context is reflected in key changes in evidence, recommendations and format in the major revision of the GINA strategy report that was published in May
2014, and further updated in April 2015.
Since the last major revision of the GINA report in 2006 [12], there has been a transition in understanding of asthma and chronic obstructive pulmonary disease (COPD) as heterogeneous and sometimes overlapping conditions, awareness of the contribution of common problems such as adherence, inhaler technique and health literacy to poorly controlled asthma, an expanding research evidence base that incorporates highly controlled efficacy studies, pragmatic studies and observational data in broad populations [13], increasing interest in individualised healthcare, and growing attention to effective strategies for changing health-related behaviour. This context is reflected in key changes in evidence, recommendations and format in the major revision of the GINA strategy report that was published in May2014, and further updated in April 2015.
การแปล กรุณารอสักครู่..
